These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 3783903)

  • 21. Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-I-synthase activity.
    Mustajoki P; Tenhunen R
    Eur J Clin Invest; 1985 Oct; 15(5):281-4. PubMed ID: 3935460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of effect of pregnancy or hematin therapy on erythrocyte porphobilinogen deaminase activity in acute intermittent porphyria.
    Sassa S; Kappas A
    N Engl J Med; 1989 Jul; 321(3):192-3. PubMed ID: 2747754
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter: Screening test for intermittent acute porphyria.
    Tishler PV; Knighton DJ; Schumaker HM
    Lancet; 1976 Feb; 1(7954):303. PubMed ID: 55612
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of uroporphyrinogen I synthase in whole blood--a method for the diagnosis and early recognition of acute intermittent porphyria].
    Druschky KF; Schaller KH; Kammerer H
    Verh Dtsch Ges Inn Med; 1975; 81():1459-62. PubMed ID: 1226996
    [No Abstract]   [Full Text] [Related]  

  • 25. Erythrocyte uroporphyrinogen-I-synthetase activity in acute intermittent porphyria.
    Wilson JH; van den Berg JW; Brouwers D; Coppens K; van Zellem J
    Neth J Med; 1979; 22(1):13-6. PubMed ID: 418940
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutations in acute intermittent porphyria detected by ELISA measurement of porphobilinogen deaminase.
    Lannfelt L; Wetterberg L; Gellerfors P; Lilius L; Floderus Y; Thunell S
    J Clin Chem Clin Biochem; 1989 Nov; 27(11):857-62. PubMed ID: 2607315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of erythrocyte hydroxymethylbilane synthase activity and its application for study of acute intermittent porphyria.
    Lee FY; Hsiao KJ; Tsai YT; Lee SD; Wu SJ; Jeng HS
    Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1029-35. PubMed ID: 3235962
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-cost uroporphyrinogen I synthase screening for acute intermittent porphyria.
    Brocklehurst D
    Clin Chem; 1978 Apr; 24(4):730-1. PubMed ID: 639289
    [No Abstract]   [Full Text] [Related]  

  • 29. Uroporphyrinogen synthetase in erythrocytes. Its diagnostic value in latent acute intermittent porphyria with special regard to the gene penetrance.
    With TK; Pedersen JS
    Dan Med Bull; 1981 Mar; 28(1):27-34. PubMed ID: 7238130
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis of acute intermittent porphyria on the basis of uroporphyrinogen I synthase activity in the erythrocytes; comparison of 2 methods].
    Kostrzewska E; Gregor A; Traczyk A; Rudowski W
    Pol Tyg Lek; 1979 Aug; 34(33):1305-7. PubMed ID: 514844
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular forms of porphobilinogen deaminase in acute intermittent porphyria. A study by Western immunoblotting.
    Nunn AV; Gardner LC; Cox TM
    Q J Med; 1987 Jul; 64(243):589-99. PubMed ID: 3671663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Normal activity of uroporphyrinogen I synthase during an attack of acute intermittent porphyria].
    Kostrzewska E; Gregor A
    Pol Tyg Lek; 1980 Nov; 35(46):1785-6. PubMed ID: 7243643
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase.
    Grandchamp B; Picat C; Kauppinen R; Mignotte V; Peltonen L; Mustajoki P; Roméo PH; Goossens M; Nordmann Y
    Eur J Clin Invest; 1989 Oct; 19(5):415-8. PubMed ID: 2511016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnosis of acute intermittent porphyria. Usefulness and limitations of the erythrocyte uroporphyrinogen I synthase assay.
    Bottomley SS; Bonkowsky HL; Kreimer-Birnbaum M
    Am J Clin Pathol; 1981 Aug; 76(2):133-9. PubMed ID: 7270494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic heterogeneity in acute intermittent porphyria: characterisation and frequency of porphobilinogen deaminase mutations in Finland.
    Mustajoki P; Desnick RJ
    Br Med J (Clin Res Ed); 1985 Aug; 291(6494):505-9. PubMed ID: 3928029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythrocyte uroporphyrinogen I synthase activity in diagnosis of acute intermittent porphyria.
    Peterson LR; Hamernyik P; Bird TD; Labbé RF
    Clin Chem; 1976 Nov; 22(11):1835-40. PubMed ID: 975542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red cell uroporphyrinogen I synthetase in acute intermittent porphyria.
    Mustajoki P
    Ann Clin Res; 1976; 8 Suppl 17():133-8. PubMed ID: 1008483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why is the patient with acute intermittent porphyria not light sensitive?
    Wetterberg L; Thunell S; Zetterlund P
    Acta Derm Venereol Suppl (Stockh); 1982; 100():73-4. PubMed ID: 6962637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic studies of families of patients with porphyria. Determination of uroporphyrinogen I synthase in the erythrocytes].
    Gregor A; Kostrzewska E; Kocyłowski M; Rudowski W
    Pol Arch Med Wewn; 1979 Jul; 62(1):15-21. PubMed ID: 503882
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic regulation of the red cell uroporphyrinogen-I-synthetase level in families with acute intermittent porphyria.
    Wetterberg L; Floderus Y; Thunell S; Iselius L; Lindsten J
    Clin Genet; 1983 Dec; 24(6):403-6. PubMed ID: 6652953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.